Britain’s payments watchdog will review banks who process card transactions on behalf of merchants, such as retailers, following concerns that customers may not be getting the best deal reported the Financial Times. The Payments Systems Regulator (PSR) on Tuesday said it was concerned that some retailers “are suffering significant harm because competition in the supply of card-acquiring services is not working well.”
The PSR published draft terms of its review into card-acquiring services provided by the mayor who accept and process card payments on behalf of a merchant for a fee.
Card acquirers have become increasingly essential for retailers as consumers have moved away from cash payments in recent years. In 2017 debit cards overtook cash as the most frequently-used payment form in the UK, and the trend is forecast to accelerate further.
The regulator announced it would also be looking into broader issues in the card-acquiring business, including a lack of transparency around fees and whether firms have made it too difficult for retailers to compare between and switch to different acquirers.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan